Jia Luo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Small Cell Lung Cancer

Long Noncoding Rna

Top Venues

JCO precision oncology

Cancer discovery

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Dilanka Lakshan De Silva, Jia Luo
Clinical approach and utilizing liquid biopsies to interrogate suspected acquired resistance to PD-1 blockade. Future science OA 10 (1) (2024)
Ezra Bernstein, Jia Luo, Kaiwen Wang, Marcelo Vailati Negrão, Pasi A Janne, Joshua K Sabari
Safety and Intracranial Activity of Adagrasib in Patients With KRAS G12C -Mutated Non-Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series. JCO precision oncology 8 (2024)
Ezra Bernstein, Jia Luo, Kaiwen Wang, Marcelo Vailati Negrão, Pasi A Janne, Joshua K Sabari
Safety and Intracranial Activity of Adagrasib in Patients With KRAS G12C -Mutated Non-Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series. JCO precision oncology 8 (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Dilanka Lakshan De Silva, Jia Luo
Clinical approach and utilizing liquid biopsies to interrogate suspected acquired resistance to PD-1 blockade. Future science OA 10 (1) (2024)
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M Muldoon, Hira A Rizvi, Arielle Elkrief, Jia Luo, Joao M Victor Alessi, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Lingzhi Hong, Jianjun Zhang, John Victor Heymach, Don L Gibbons, Andrew J Plodkowski, Vignesh Ravichandran, Mark T A Donoghue, Chad M Vanderbilt, Marc Ladanyi, Charles M Rudin, Mark G Kris, Gregory J Riely, Jamie E Chaft, Matthew D Hellmann, Natalie I Vokes, Mark M Awad, Adam J Schoenfeld
Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yeying Huang, R Taylor Durall, Nhi M Luong, Hans J Hertzler, Julianna Huang, Prafulla C Gokhale, Brittaney A Leeper, Nicole S Persky, David E Root, Praju Vikas Anekal, Paula Montero Llopis, Clement N David, Jeffery L Kutok, Alejandra Raimondi, Karan Saluja, Jia Luo, Cynthia A Zahnow, Biniam Adane, Kimberly Stegmaier, Catherine E Hawkins, Christopher Ponne, Quan Le, Geoffrey I Shapiro, Madeleine E Lemieux, Kyle P Eagen, Christopher A French
EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes. Cancer research (2023)
Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Benjamin Karasic, Laura Medina, Einat Shacham-Shmueli, Rasha Cosman, Alejandro Falcón Gonzalez, Eelke Gort, Tormod Kyrre Guren, Erminia Massarelli, Wilson H Miller, Luis Paz-Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Victor Moreno, Sai-Hong Ignatius Ou, Alessandro Passardi, Adrian Sacher, Armando Santoro, Rafal Stec, Susanna Ulahannan, Kathryn C Arbour, Patricia M LoRusso, Jia Luo, Manish R Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T Lin, Stephanie Royer-Joo, Julie Chang, Tomi Jun, Neekesh V Dharia, Jennifer L Schutzman, null null, Sae-Won Han
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial. Nature medicine (2023)
R Taylor Durall, Julianna Huang, Luke Wojenski, Yeying Huang, Prafulla C Gokhale, Brittaney A Leeper, Joshua O Nash, Pedro L Ballester, Scott Davidson, Adam Shlien, Emmanuel Sotirakis, Fabien Bertaux, Vincent Dubus, Jia Luo, Catherine J Wu, Derin B Keskin, Kyle P Eagen, Geoffrey I Shapiro, Christopher A French
The BRD4-NUT fusion alone drives malignant transformation of NUT carcinoma. Cancer research (2023)
Jason Beattie, Hira Rizvi, Paige Fuentes, Jia Luo, Adam Schoenfeld, I-Hsin Lin, Michael Postow, Margaret Callahan, Martin H Voss, Neil J Shah, Allison Betof Warner, Mohit Chawla, Matthew D Hellmann
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade. Journal for immunotherapy of cancer 9 (2) (2022)
Paul K Paik, Jia Luo, Ni Ai, Rachel Kim, Linda Ahn, Anup Biswas, Courtney Coker, Wanchao Ma, Phillip Wong, Darren J Buonocore, W Victoria Lai, Jamie E Chaft, Swarnali Acharyya, Joan Massagué, Mark G Kris
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas. Nature communications 13 (1) (2022)
Rami S Vanguri, Jia Luo, Andrew T Aukerman, Jacklynn V Egger, Christopher J Fong, Natally Horvat, Andrew Pagano, Jose de Arimateia Batista Araujo-Filho, Luke Geneslaw, Hira Rizvi, Ramon Sosa, Kevin Michael Boehm, Soo-Ryum Yang, Francis M Bodd, Katia Ventura, Travis J Hollman, Michelle S Ginsberg, Jianjiong Gao, null null, Matthew D Hellmann, Jennifer L Sauter, Sohrab P Shah
Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer. Nature cancer 3 (10) (2022)
Jia Luo, Victoria L Martucci, Zoe Quandt, Stefan Groha, Megan H Murray, Christine M Lovly, Hira Rizvi, Jacklynn V Egger, Andrew J Plodkowski, Mohsen Abu-Akeel, Isabell Schulze, Taha Merghoub, Eduardo Cardenas, Scott Huntsman, Min Li, Donglei Hu, Matthew A Gubens, Alexander Gusev, Melinda C Aldrich, Matthew D Hellmann, Elad Ziv
Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (18) (2021)
Joao M Victor Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, Fangxin Hong, Zihan Wei, Mizuki Nishino, Andrew J Plodkowski, Peter Sawan, Jia Luo, Hira Rizvi, Brett W Carter, John V Heymach, Mehmet Altan, Matthew Hellmann, Mark Awad
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status. Journal for immunotherapy of cancer 8 (2) (2021)
Robin Guo, Jia Luo, Jason C Chang, Natasha Rekhtman, Maria Arcila, Alexander E Drilon
MET-dependent solid tumours - molecular diagnosis and targeted therapy. Nature reviews. Clinical oncology 17 (9) (2020)
Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D Wolchok, Matthew D Hellmann
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers. Cancer discovery 10 (8) (2020)
Qu Zhang, Jia Luo, Song Wu, Han Si, Chen Gao, Wenjing Xu, Shaad E Abdullah, Brandon W Higgs, Phillip A Dennis, Michiel S van der Heijden, Neil H Segal, Jamie E Chaft, Todd Hembrough, J Carl Barrett, Matthew D Hellmann
Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade. Cancer discovery 10 (12) (2020)
Kathryn C Arbour, Anh Tuan Luu, Jia Luo, Hira Rizvi, Andrew J Plodkowski, Mustafa Sakhi, Kevin B Huang, Subba R Digumarthy, Michelle S Ginsberg, Jeffrey Girshman, Mark G Kris, Gregory J Riely, Adam Yala, Justin F Gainor, Regina Barzilay, Matthew D Hellmann
Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade. Cancer discovery 11 (1) (2020)